Treatment of melasma with oral administration of tranexamic acid

Aesthetic Plastic Surgery

Volumn 36, Issue 4, 2012, Pages 964-970

  Wu, Sufan ^a   Shi, Hangyan ^a   Wu, Hua ^a   Yan, Sheng ^a   Guo, Jincai ^a   Sun, Yi ^a   Pan, Lei ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Melasma; Oral administration; Tranexamic acid

Indexed keywords

DERMATOLOGICAL AGENT; TRANEXAMIC ACID;

ADULT; ARTICLE; ASIAN; CHINA; FEMALE; HUMAN; MALE; MELANOSIS; ORAL DRUG ADMINISTRATION; PATIENT SATISFACTION; SKIN PIGMENTATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MELANOSIS; PATIENT SATISFACTION; SKIN PIGMENTATION; TRANEXAMIC ACID; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84866412399     PISSN: 0364216X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00266-012-9899-9     Document Type: Conference Paper

References (35)

1. Johnston GA, Sviland L, Mclelland J (1998) Melasma of the arms associated with hormone replacement therapy. Br J Dermatol 139:932
2. Scheinfeld NS (2007) Melasma. Skinmed 6:35-37
3. Victor FC, Gelber J, Rao B (2004) Melasma: a review. J Cutan Med Surg 8:97-102
4. Rendon M, Berneburg M, Arellano I, Picardo M (2006) Treatment of melasma. J Am Acad Dermatol 54:S272-S281
5. Lakhdar H, Zouhair K, Khadir K, Essari A, Richard A, Seité S, Rougier A (2007) Evaluation of the effectiveness of a broadspectrum sunscreen in the prevention of chloasma in pregnant women. JEADV 21:738-742
6. Costin GE, Birlea SA (2006) What is the mechanism for melasma that so commonly accompanies human pregnancy? IUBMB Life 58:55-57
7. Moin A, Jabery Z, Fallah N (2006) Prevalence and awareness of melasma during pregnancy. Int J Dermatol 45:285-288
8. Perez M, Sanchez JL, Aguilo F (1983) Endocrinologic profile of patients with idiopathic melasma. J Invest Dermatol 81:543-545
9. Foldes EG (1988) Pharmaceutical effect of contraceptive pills on the skin. Int J Clin Pharmacol Ther Toxicol 26:356-359
10. Resnick S (1967) Melasma induced by oral contraceptive drugs. JAMA 199:601-605
11. Prignano F, Ortonne J, Buggiani G, Lotti T (2007) Therapeutical approaches in melasma. Dermatol Clin 25:337-342
12. Cuce LC, Bertino M, Scattone L, Birkenhauer MC (2001) Tretinoin peeling. Dermatol Surg 27:12-14
13. Palumbo A, D'ischia M, Misuraca G, Proto G (1073) Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 85-90:1991
14. Romero C, Aberdam E, Larnier C, Ortonne JP (1994) Retinoic acid as modulator of UVB-induced melanocyte differentiation. J Cell Sci 107:1095-1103
15. Bhawan J (1998) Short- and long-term histologic effects of topical tretinoin on photodamaged skin. Int J Dermatol 37:286-292
16. Sato K, Matsumoto D, Iizuka F, Aiba-Kojima E, Machino C, Suga H, Watanabe-Ono A, Inoue K, Gonda K, Yoshimura K (2007) A clinical trial of topical bleaching treatment with nanoscale tretinoin particles and hydroquinone for hyperpigmented skin lesions. Dermatol Surg 33:937-944
17. Sharquie KE, Al-tikreety MM, Al-mashhadani SA (2005) Lactic acid as a new therapeutic peeling agent in melasma. Dermatol Surg 31:149-154
18. Erbil H, Sezer E, Tastan B, Arca E, Kurumlu Z (2007) Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 34:25-30
19. Cabanes J, Chazarra S, Garcia-Carmona F (1994) Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of cathecolase activity of tyrosinase. J Pharm Pharmacol 46:982-985
20. Nakagawa M, Kawai K, Kawai K (1995) Contact allergy to kojic acid in skin care products. Contact Dermat 32:9-13
21. Angsuwarangsee S, Polnikorn N (2003) Combined ultrapulse CO2 laser and Q-switched Alexandrite laser compared with Q-switched Alexandrite laser alone for refractory melasma. Dermatol Surg 29:59-64
22. Manaloto RM, Alster T (1999) Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 25:121-123
23. Rokhsar CK, Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 31:1645-1650
24. Negishi K, Kushikata N, Tezuka Y, Takeuchi K, Miyamoto E, Wakamatsu S (2004) Study of the incidence and nature of "very subtle epidermal melasma" in relation to intense pulsed-light treatment. Dermatol Surg 30:881-886
25. Wang CC, Hui CY, Sue YM (2004) Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol Surg 30:1196-1200
26. Dunn CJ, Goa KL (1999) Tranexamic acid: a review of its use in surgery and other indications. Drugs 57:1005-1032
27. Nijor T (1979) Treatment of melasma with tranexamic acid. Clin Res 13:3129-3131 (in Japanese)
28. Lee JH, Park JG, Lim SH, Kim JY, Ahn KY, Kim MY, Park YM (2006) Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial. Dermatol Surg 32:626-631
29. Grimes PE (1995) Melasma: etiologic and therapeutic considerations. Arch Dermatol 131:1453-1457
30. Grimes PE, Yamada N, Bhawan J (2005) Light microscopic, immunohistochemical, and ultrastructural alterations in patients with melasma. Am J Dermatopathol 27:96-101
31. Barrientos N, Ortiz-Frutos J, Gomez E, Iglesias L (2001) Allergic contact dermatitis from a bleaching cream. Am J Contact Dermat 12:33-34
32. Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J (1999) Combination treatment of melasma with pulsed CO2 laser followed by Q-switched Alexandrite laser: a pilot study. Dermatol Surg 25:494-497
33. Maeda K, Naganuma M (1998) Topical trans-4- aminomethylcyclohexanecarboxylic acid prevents ultraviolet radiation-induced pigmentation. Photochem Photobiol 47:130-141
34. Maeda K, Tomitab Y (2007) Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium. J Health Sci 53:389-396
35. Zhang X, Yang X, Yang H, Yang Y (2003) Study of inhibitory effect of acidum tranexamicum on melanin synthesis. Chin J Dermatovenerol Integr Tradit West Med 2:227-229